Subgroup analyses according to predefined factors including neonatal gender, geographical region, measurement method, birth weight, diagnostic criterion, maternal androgen, and maternal BMI suggested that higher AMH levels were observed female neonates and neonates born to American and Asian PCOS patients, diagnosed by the NIH criteria, with maternal hyperandrogenism or maternal BMI >30 kg/m2. The gene discussed is AMH; the disease is hyperandrogenism.